by Nick | Mar 10, 2022 | Clinical Research, Pharmacovigilance, Regulatory Affairs
Like the rest of the world, the pharmaceutical and biotech industries are beginning to worry about their ability to continue operations. And, with good reason. Russia’s invasion of Ukraine affects millions of people, not just in this Eastern European nation but...
by Nick | Feb 23, 2022 | Clinical Research
Clinical development of oncology drugs has one of the lowest success rates of the development of Investigational New Drugs (INDs) for all disease categories, with less than 7% of phase I-tested oncology drugs achieving market approval. Moreover, the clinical...
by Nick | Feb 9, 2022 | Clinical Research, oncology
The difficulties of recruiting in clinical trials, and particularly cancer patients in their early stages, can significantly obstruct the development of innovative treatments. There is an undeniable increase in demand for Early Phase Clinical studies in patients to...
by Nick | Jan 10, 2022 | Clinical Research
Choosing the right setting for your early phase trial can be challenging. As a sponsor, it’s natural to remain cautious about running more extensive early-phase patient trials in a single Phase I unit due predominantly to the doubt over actually being able to...
by Kamile Gruduls | Dec 2, 2021 | Clinical Research, News
December 2021 Biomapas has joined the SwedenBIO organization starting November 2021. Joining SwedenBIO’s mission to promote an environment bringing success and growth to the entire Swedish life science industry, we seek to walk the path in developing the life...
by Nick | Nov 16, 2021 | Clinical Research
The COVID-19 pandemic has accelerated the adoption of decentralized clinical trials by emphasizing the tangible advantages of virtual trials and their ability to improve the patient and physician experience. Moreover, it requires stakeholders to devote time and...
